Novel insulin sensitizer MSDC-0602K improves insulinemia and fatty liver disease in mice, alone and in combination with liraglutide.
Saved in:
| Title: | Novel insulin sensitizer MSDC-0602K improves insulinemia and fatty liver disease in mice, alone and in combination with liraglutide. |
|---|---|
| Authors: | Kamm DR; Biochemistry & Molecular Biology, Saint Louis University School of Medicine, St Louis, Missouri, USA., Pyles KD; Biochemistry & Molecular Biology, Saint Louis University School of Medicine, St Louis, Missouri, USA., Sharpe MC; Biochemistry & Molecular Biology, Saint Louis University School of Medicine, St Louis, Missouri, USA., Healy LN; LNH Tox Path Consulting LLC, Newbury Park, California, USA., Colca JR; Cirius Therapeutics, Kalamazoo, Michigan, USA; Cirius Therapeutics, San Diego, California, USA., McCommis KS; Biochemistry & Molecular Biology, Saint Louis University School of Medicine, St Louis, Missouri, USA. Electronic address: kyle.mccommis@health.slu.edu. |
| Source: | The Journal of biological chemistry [J Biol Chem] 2021 Jan-Jun; Vol. 296, pp. 100807. Date of Electronic Publication: 2021 May 20. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Inc. on behalf of American Society for Biochemistry and Molecular Biology Country of Publication: United States NLM ID: 2985121R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1083-351X (Electronic) Linking ISSN: 00219258 NLM ISO Abbreviation: J Biol Chem Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1083-351X |
|---|---|
| DOI: | 10.1016/j.jbc.2021.100807 |
